: A topical JAK inhibitor recently approved for short-term control. 3. Phototherapy

Management of atopic dermatitis (AD) has evolved from simple symptom relief to a multi-tiered approach focused on barrier repair, inflammation control, and targeted systemic therapies.

Narrowband UVB (311 nm) or UVA1 phototherapy serves as an adjuvant for moderate-to-severe disease that is refractory to topicals. It has antimicrobial effects and modulates the skin's immune response.

Prescription topicals are used for acute flare control and proactive maintenance.

: Ointments and creams are generally superior to lotions for barrier repair. Newer formulations may include ceramides or filaggrin breakdown products.

: The first-line therapy for flares. They range from low to ultra-high potency, with selection based on patient age and affected body site (e.g., low-potency for the face).

: These are essential for all patients, even during remission.

: Short (5–10 minute) baths in tepid water with fragrance-free, soap-free cleansers help cleanse and hydrate the skin without causing irritation. 2. Topical Anti-Inflammatory Therapies

Atopic Dermatitis Therapy -

: A topical JAK inhibitor recently approved for short-term control. 3. Phototherapy

Management of atopic dermatitis (AD) has evolved from simple symptom relief to a multi-tiered approach focused on barrier repair, inflammation control, and targeted systemic therapies.

Narrowband UVB (311 nm) or UVA1 phototherapy serves as an adjuvant for moderate-to-severe disease that is refractory to topicals. It has antimicrobial effects and modulates the skin's immune response. ATOPIC DERMATITIS THERAPY

Prescription topicals are used for acute flare control and proactive maintenance.

: Ointments and creams are generally superior to lotions for barrier repair. Newer formulations may include ceramides or filaggrin breakdown products. : A topical JAK inhibitor recently approved for

: The first-line therapy for flares. They range from low to ultra-high potency, with selection based on patient age and affected body site (e.g., low-potency for the face).

: These are essential for all patients, even during remission. Narrowband UVB (311 nm) or UVA1 phototherapy serves

: Short (5–10 minute) baths in tepid water with fragrance-free, soap-free cleansers help cleanse and hydrate the skin without causing irritation. 2. Topical Anti-Inflammatory Therapies